News and media

We are seeking expressions of interest to fill 7 vacancies on the Australian Technical Advisory Group on Immunisation (ATAGI), commencing 1 July 2023. Consider applying if you are a clinical professional, researcher, service delivery expert or consumer expert.

In 2020, 5 Australian research organisations with expertise in infectious diseases and 2 industry partners formed a consortium. Their aim: to produce an Australian antiviral drug for COVID-19. This research is growing Australia’s ability to discover, test, and manufacture antiviral drugs.

From 21 December 2022, vaccination providers must report all Japanese encephalitis virus (JEV) vaccines administered to the Australian Immunisation Register (AIR).

If you are considering cosmetic surgery, it is important that you get trustworthy information first. Information and resources are now available to help you make the safer choice.

See details on the pre-departure testing requirement for COVID-19 for people travelling to Australia from China, including Hong Kong and Macau.

The Minister for Health has determined the end of the COVIDSafe data period effective from 16 August 2022. All COVIDSafe app data has now been deleted from the National COVIDSafe Data Store. 

The Australian Government will introduce pre-departure testing for COVID-19 for people travelling to Australia from the People’s Republic of China.

How can 13YARN help you?

Most people look forward to the holiday season, but others may find it a challenging time for many different reasons. It is not uncommon for people to feel isolated, sad or anxious, so you’re not alone if you find yourself feeling down this Christmas.

Researchers can apply for funding under the 2022 Frontier Health and Medical Research grant opportunity from 13 February 2023. Funding is from the Medical Research Future Fund (MRFF).

The Oceania Asia Games 2022 leaves a lasting legacy.

Researchers can apply for funding under the 2022 Clinical Trials Activity grant opportunity. Funding is from the Medical Research Future Fund (MRFF).

Blocked arteries cause heart attacks by reducing oxygen flow to the heart. Called ischemia, this leads to the death of heart cells. These injuries are permanent and can cause the heart to fail. A new drug could prevent this damage.

The Australian Government is committed to supporting effective COVID-19 testing to limit the spread and ensure that those most at risk of severe disease have fast access to care and treatments.

Researchers can apply for funding under the 2022 Mental Health Research grant opportunity. Funding is from the Medical Research Future Fund (MRFF).

Researchers can apply for funding under the 2022 Rapid Applied Research Translation grant opportunity from 9 January 2023. Funding is from the Medical Research Future Fund (MRFF).

The DNA Screen study offers free DNA screening for high-risk hereditary disease gene variants to 10,000 young Australians. When the study launched it received national media coverage. Over 20,000 people registered in the first 3 days. We asked lead researcher Paul Lacaze what happened next.

Some people who are at higher risk of getting very ill from COVID-19 are eligible for the COVID-19 oral treatments.

During the upcoming holidays it is important that we stay COVIDSafe. As we start to enjoy our summer, we need to be aware the next wave of COVID-19 has arrived. Cases are again on the increase. We know that what can be a mild illness for some people can be life threatening for others.

We recognise and celebrates our dedicated aged care volunteers today on International Volunteer Day.